Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

SANTA CLARA, California, September 29 /PRNewswire/ --

- Consultancy Leverages IntelliCorp to Eliminate Risk and Reduce Cost for SAP Customers

IntelliCorp, a worldwide provider of application lifecycle management, business process and data management software for SAP users, today announced a partnership with SQS, a global leader in independent software testing and quality management services, to bring SAP customers advanced Quality Assurance (QA) software that reduces the risk and cost associated with SAP lifecycle changes.

SUNNYVALE, California, September 29 /PRNewswire/ --

- Spirent TestCente(TM) Enables Interoperability Testing of Carrier Ethernet in Real-World Network Environments

Spirent Communications plc (LSE: SPT), a global provider of performance analysis and service management solutions, advances Carrier Ethernet networks and services by supporting the European Advanced Networking Test Center (EANTC) Interoperability Showcase at Carrier Ethernet World Congress 2008 in Berlin, Germany. Spirent, with its award-winning Spirent TestCenter(TM) platform collaborated with EANTC and over 2 dozen vendors to reliably test and analyze interoperability of complex Carrier Ethernet services and technologies.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080909/CLTU016LOGO )

SANTA CLARA, California and CAMBRIDGE, England, September 29 /PRNewswire/ --

- ARM to Develop and License Comprehensive Physical IP Design Platform Targeted at Achieving Optimal Power, Performance, and Area for Current and Future ARM Cortex Processors

IBM (NYSE: IBM), Chartered Semiconductor Manufacturing Ltd. (Nasdaq: CHRT, SGX-ST: CHARTERED) Samsung Electronics, Co., Ltd., and ARM [(LSE: ARM); (Nasdaq: ARMH)] today announced they will develop a comprehensive 32 nanometer (nm) and 28nm Systems-on-a-Chip (SoCs) design platform based on high-k metal-gate (HKMG) technology from the IBM-led joint-development alliance.

BRUSSELS, Belgium - Broadband World Forum, September 29 /PRNewswire/ -- At the Broadband World Forum 2008 tradeshow and exhibition today, Alcatel-Lucent (Euronext Paris and NYSE: ALU) is announcing a significant evolution of its industry-leading Triple Play Services Delivery Architecture (TPSDA), providing a foundation for service providers to deliver superior video quality, with greater personalisation and interactivity.

BEIJING, September 29 /PRNewswire/ --

- Claim Stems from LoJack's Termination of China Technology License

Kington Holdings Ltd ("Kington") announced today that it has filed a counterclaim in proceedings with the American Arbitration Association against LoJack Equipment Ireland Ltd ("LoJack Ireland"), a subsidiary of LoJack Corporation (Nasdaq: LOJN) ("LoJack"), a provider of recovery systems for stolen vehicles.

The dispute arose from LoJack Ireland's termination of a Technology License agreement for China on 12th November 2007, after which LoJack filed for arbitration for alleged damages in the amount of US$5,000,000 and enforcement of certain post-termination provisions.

BRITISH COLUMBIA, Canada, September 29 /PRNewswire/ --

- Receives Recognition in Two Leading Industry Publications

InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces Jeff Morhet, CEO and Chairman, to present during BioContactQuebec 2008. The company also announces the featuring of Mr. Morhet in two leading publications, Genetic Engineering & Biotechnology News and The PharmaVoice List of Top 100 in Life Sciences.